Search
for
Sort by
Research 61–90 of 1000+
- Diseases of the skin. Drug ill effects on the skin.
- Hair loss due to methylphenidate use: A case study
- DRUG‐ASSOCIATED ALOPECIA
- Reporting on Adverse Clinical Events
- Psoriasis
- Psychoactive drugs and skin
- Dermatologic implications of COVID-19 infection and immunization: hair loss
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Adverse Cutaneous Reactions to Antipsychotics
- A Review of Hair Anatomy and Animal Models for Alopecia
- Feline Symmetrical Alopecia
- Finasteride-induced recurrent aphthous ulceration–like lesions: a case report with dechallenge–rechallenge confirmation
- Drug Repurposing Patent Applications April–June 2021
- An overview of management of drug-induced hair and nail disorders
- Acute Alopecia Associated With Albendazole Toxicosis
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Diagnostic challenges in determining alopecia areata
- Acute Alopecia Associated With Albendazole Toxicosis
- Nonscarring Alopecias
- Alopecia caused by isoniazid
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Ban Tu Wan hepatotoxicity
- Baricitinib Induced Hypoglycemic Seizures in a Patient with Hair Loss and Type I Diabetes Mellitus: A Case Report
- Application of phototherapy in alopecia
- Anti-androgenetic effect of diphlorethohydroxycarmalol on testosterone-induced hair loss by inhibiting 5α-reductase and promoting Wnt/β-catenin signaling pathway in human dermal papilla cells
- Photosensitivity reaction induced by finasteride
- A pathophysiological and clinical review of androgenetic , areata, anagen effluvium, telogen effluvium and traction alopecia’s
- Rivaroxaban-induced hair loss
- Hair Loss Induced by Lopinavir-Ritonavir
- Drugs and Androgenetic Alopecia: What to look out for